These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1230 related articles for article (PubMed ID: 832241)

  • 1. Some aspects of the treatment of primary malignant melanoma of the extremities by isolated regional perfusion.
    Schraffordt Koops H; Oldhoff J; van der Ploeg E; Vermey A; Eibergen R; Beekhuis H
    Cancer; 1977 Jan; 39(1):27-33. PubMed ID: 832241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Isolated hyperthermic perfusion of extremities in malignant melanoma with melphalan and tumor necrosis factor].
    Kettelhack C; Hohenberger P; Schlag PM
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():127-9. PubMed ID: 9101810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolated limb perfusion for unresectable melanoma of the extremities.
    Noorda EM; Vrouenraets BC; Nieweg OE; van Geel BN; Eggermont AM; Kroon BB
    Arch Surg; 2004 Nov; 139(11):1237-42. PubMed ID: 15545572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of regional hyperthermic perfusion for primary and recurrent melanomas of the extremities.
    Jönsson PE; Hafström L; Hugander A
    Recent Results Cancer Res; 1983; 86():277-82. PubMed ID: 6648009
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term outcome of hyperthermic isolated limb perfusion (HILP) in the treatment of locoregionally metastasised malignant melanoma of the extremities.
    Boesch CE; Meyer T; Waschke L; Merkel S; Goehl J; Hohenberger W; Knorr C
    Int J Hyperthermia; 2010 Feb; 26(1):16-20. PubMed ID: 20100048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeat isolated limb perfusion with TNFalpha and melphalan for recurrent limb melanoma after failure of previous perfusion.
    Noorda EM; Vrouenraets BC; Nieweg OE; van Geel AN; Eggermont AM; Kroon BB
    Eur J Surg Oncol; 2006 Apr; 32(3):318-24. PubMed ID: 16412605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant regional isolated perfusion with melphalan for patients with Clark V melanoma of the extremities.
    Vrouenraets BC; Kroon BB; Klaase JM; Van Geel BN; Eggermont AM; Franklin HR
    J Surg Oncol; 1993 Apr; 52(4):249-54. PubMed ID: 8468989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation perfusion. An adjunct to surgical excision in the primary treatment of melanoma of the extremities.
    Alrich EM; Manwaring JL; Horsley JS
    Am J Surg; 1971 May; 121(5):583-5. PubMed ID: 5557770
    [No Abstract]   [Full Text] [Related]  

  • 9. Malignant melanoma and isolated limb perfusion.
    Giraud RM
    S Afr J Surg; 1984; 22(4):243-8. PubMed ID: 6523302
    [No Abstract]   [Full Text] [Related]  

  • 10. Isolated limb perfusion for malignant melanoma.
    Rosin RD; Westbury G
    Practitioner; 1980 Oct; 224(1348):1031-6. PubMed ID: 7220430
    [No Abstract]   [Full Text] [Related]  

  • 11. Hyperthermic isolation-perfusion with melphalan, a preliminary appraisal of local and general effects in malignant melanoma.
    Lejeune FJ; Mathieu M; Kenis Y
    Tumori; 1977; 63(3):289-98. PubMed ID: 898296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperthermic perfusion of extremities for melanoma and soft tissue sarcomas.
    Stehlin JS; Giovanella BC; de Ipolyi PD; Muenz LR; Anderson RF; Gutierrez AA
    Recent Results Cancer Res; 1977; (59):171-85. PubMed ID: 408886
    [No Abstract]   [Full Text] [Related]  

  • 13. Prophylactic isolation-perfusion as the primary therapy for invasive malignant melanoma of the limbs.
    McBride CM; Sugarbaker EV; Hickey RC
    Ann Surg; 1975 Sep; 182(3):316-24. PubMed ID: 1164059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of hyperthermic perfusion for melanoma of the extremities.
    Stehlin JS; Giovanella BC; de Ipolyi PD; Muenz LR; Anderson RF
    Surg Gynecol Obstet; 1975 Mar; 140(3):339-48. PubMed ID: 1114425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of two methods of treating primary malignant melanomas Clark IV and V, thickness 1.5 mm and greater, localized on the extremities. Wide surgical excision with and without adjuvant regional perfusion.
    Martijn H; Schraffordt Koops H; Milton GW; Nap M; Oosterhuis JW; Shaw HM; Oldhoff J
    Cancer; 1986 May; 57(10):1923-30. PubMed ID: 3955499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of age on outcomes after isolated limb perfusion for advanced extremity malignancies.
    Smith HG; Wilkinson MJ; Smith MJF; Strauss DC; Hayes AJ
    Eur J Cancer; 2018 Sep; 100():46-54. PubMed ID: 29940423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of regional limb perfusion with melphalan for malignant melanoma.
    Irvine WT; Luck RJ
    Br Med J; 1966 Mar; 1(5490):770-4. PubMed ID: 5910107
    [No Abstract]   [Full Text] [Related]  

  • 18. Tumour response after hyperthermic isolated limb perfusion for locally advanced melanoma.
    Paulsen IF; Chakera AH; Drejøe JB; Klyver H; Dahlstrøm K; Oturai PS; Mortensen J; Hesse B; Schmidt G; Drzewiecki K
    Dan Med J; 2014 Jan; 61(1):A4741. PubMed ID: 24393586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic hyperthermic limb perfusion in stage I melanoma.
    Krige JE; King HS; Strover RM
    Eur J Surg Oncol; 1988 Aug; 14(4):321-6. PubMed ID: 3044834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolated limb perfusion for localized melanoma of the extremity. A matched comparison of wide local excision with isolated limb perfusion and wide local excision alone.
    Edwards MJ; Soong SJ; Boddie AW; Balch CM; McBride CM
    Arch Surg; 1990 Mar; 125(3):317-21. PubMed ID: 2306179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.